Advisors
Dale Pfost, Biotech Strategy Advisor
Dale is the U.S.-based General Partner of London-based Advent Life Sciences, one of the leading venture capital funds in Europe. He has been the CEO of five successful biotech companies, three of which became publicly-traded with valuations over $1 billion. He was the founding CEO of Acuity Pharmaceuticals which merged to form OPKO Health. He was the founding CEO of both Oxford GlycoSciences and Orchid BioSciences, which went public in 1998 and 2000. His first company was acquired by SmithKline Beckman. Dale has raised nearly $300 million in twenty financings and has led the M&A of nine companies. He has also served on multiple boards of directors of public and private companies. He has a PhD in Physics from Brown University and a BS from the University of California Santa Barbara.
Dale Pfost, Biotech Strategy Advisor
Dale is the U.S.-based General Partner of London-based Advent Life Sciences, one of the leading venture capital funds in Europe. He has been the CEO of five successful biotech companies, three of which became publicly-traded with valuations over $1 billion. He was the founding CEO of Acuity Pharmaceuticals which merged to form OPKO Health. He was the founding CEO of both Oxford GlycoSciences and Orchid BioSciences, which went public in 1998 and 2000. His first company was acquired by SmithKline Beckman. Dale has raised nearly $300 million in twenty financings and has led the M&A of nine companies. He has also served on multiple boards of directors of public and private companies. He has a PhD in Physics from Brown University and a BS from the University of California Santa Barbara.
